Cannabinol - 20 mg/ml in methanol
CAS: 521-35-7
Ref. 3D-FC19669
5mg | 136.00 € | ||
10mg | 188.00 € | ||
25mg | 352.00 € | ||
50mg | 548.00 € | ||
100mg | 821.00 € |
Product Information
- 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol3-Amyl-1-hydroxy-6,6 ,9-trimethyl-6H-dibenzo[b,d]pyran6,6,9-Trimethyl-3-pentyl-6H -dibenzo[b ,d]pyran-1-olCBN
- 3-Amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
- 6,6,9-Trimethyl-3-Penyl-6H-Dibenzo(B,D)Puran-1-Ol
- 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
- 6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol
- 6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
- Cannabinol
- NSC 134455
- cannabinol crystalline--dea*schedule I item
Cannabinol is a moderately psychoactive phytocannabinoid that acts as a partial agonist at the CB1 and the CB2 receptors, preferentially binding to the latter (Ki = 1130 nM and 301 nM, respectively) (Yea, 2000). In vitro binding to the CB2 receptor was demonstrated to trigger apoptotic pathways, blocking the release of cytokines in murine T lymphocytes (Munson, 1975). In vivo animal experimental models showed reduction in primary tumor size and an increase in mean survival time upon treatment with cannabinol in Lewis lung adenocarcinoma (Munson, 1975). Cannabinol was also shown to activate peripheral neuronal receptors and promote vasorelaxation, unlike other synthetic cannabinoid receptor agonists, via a CB receptor-independent mechanism.
Chemical properties
Technical inquiry about: 3D-FC19669 Cannabinol - 20 mg/ml in methanol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.